You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

March 25, 2015

Web Version  | Share with a colleague

Facebook Like Twitter Tweet

Today's Headlines

Hepatitis C therapies, compounded meds drive increase in US drug spending

New hepatitis C therapies with high price tags and the exploitation of loopholes for compounded medications drove a 13.1% increase in US drug spending in 2014—a rate not seen in more than a decade, according to Express Scripts 2014 Drug Trend Report.
» Read more

New first-in-class therapy for MS helps reduce relapse frequency

Lemtrada (alemtuzumab) received FDA approval under fast-track designation for the treatment of patients with relapsing forms of multiple sclerosis. » Details

Continuing Education

2015 Updates on the national guidelines for diabetes management and related disorders

Last month and this month pharmacists will be able to learn about the latest developments in diabetes treatment and management. Pharmacists can earn up to 4 hours of CPE credit with two monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics. The goal of this month’s activity is to discuss the recent updates of national U.S. guidelines for diabetes management, including hypertension and cholesterol management in patients with diabetes, in order to empower pharmacists in clinical decision-making.

Read/print the article: Click here

Take the test: Click here to log in with the Session Code 15DT16-TAJ88.


Announcement: Our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

EDITOR'S PICK

American College of Cardiology: NVAF patients at high risk for stroke may be undertreated

Many nonvalvular atrial fibrillation (NVAF) patients at high risk for stroke may be undertreated, according to poster presentation sessions at the American College of Cardiology (ACC) 64th Annual Scientific Session in San Diego, Calif. » Study results

 
Advertisement

RELATED ARTICLES

Move over Sovaldi: Could PCSK9 inhibitors be a bigger cost challenge?

Specialty pharmaceuticals roundtable: Balancing benefits, cost

RESOURCES

Latest Clinical News

Powered by Modern Medicine Advanstar Medical Communications Group